High resistance to fourth-generation cephalosporins among clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases isolated in Portugal

International Journal of Antimicrobial Agents

Volumn 33, Issue 2, 2009, Pages 184-185

  Fernandes, Ruben ^a   Gestoso, Álvaro ^a   Freitas, José Mota ^a   Santos, Perpétua ^a   Prudêncio, Cristina ^a  

^a POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

Author keywords

Cefepime; ESBL; Portugal

Indexed keywords

AMIKACIN; CARBAPENEM; CEPHALOSPORANIC ACID DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; CITROBACTER FREUNDII; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LETTER; LUNG LAVAGE; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEPHALOSPORINS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PORTUGAL;

EID: 58149188055     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.07.025     Document Type: Letter

References (7)

1. Livermore D.M., Canton R., Gniadkowski M., Nordmann P., Rossolini G.M., Arlet G., et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother 59 (2007) 165-174
2. Conceição T., Brízio A., Duarte A., Lito L.M., Cristino J.M., and Salgado M.J. First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal. Antimicrob Agents Chemother 49 (2005) 477-478
3. Fernandes R., Vieira M., Ferraz R., and Prudêncio C. Bloodstream infections caused by multidrug-resistant Enterobacteriaceae: report from two Portuguese hospitals. J Hosp Infect 70 (2008) 93-95
4. Queenan A.M., Foleno B., Gownley C., Wira E., and Bush K. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol 42 (2004) 269-275
5. Bhavnani S.M., Ambrose P.G., Craig W.A., Dudley M.N., and Jones R.N. SENTRY Antimicrobial Surveillance Program Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 54 (2006) 231-236
6. Grover S.S., Sharma M., Chattopadhya D., Kapoor H., Pasha S.T., and Singh G. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin. J Infect 53 (2006) 279-288
7. Hernández J.R., Martínez-Martínez L., Cantón R., Coque T.M., and Pascual A. Spanish Group for Nosocomial Infections (GEIH), Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother 49 (2005) 2122-2125